Wednesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com Biotechnology INNOVIVE PHARMACEUTL +18.00% REXAHN PHARMACEUTICL +13.40% PROGEN INDS LTD +8.90% PDL BIOPHARMA INC +7.78% NEURO-HITECH INC +7.69% Diagnostic Substances IMMUNOMEDICS INC +8.85% INTERLEUKIN GENETICS +5.15% ORCHID CELLMARK INC +4.30% PALATIN TECH INC +2.96% SYNTA PHARMACEUTICAL…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
by H.S. Ayoub
BioHealth Investor.com
Biotechnology
INNOVIVE PHARMACEUTL [IVPH.OB] +18.00%
REXAHN PHARMACEUTICL [RXHN.OB] +13.40%
PROGEN INDS LTD [PGLA] +8.90%
PDL BIOPHARMA INC [PDLI] +7.78%
NEURO-HITECH INC [NHPI.OB] +7.69%
Diagnostic Substances
IMMUNOMEDICS INC [IMMU] +8.85%
INTERLEUKIN GENETICS [ILI] +5.15%
ORCHID CELLMARK INC [ORCH] +4.30%
PALATIN TECH INC [PTN] +2.96%
SYNTA PHARMACEUTICAL [SNTA] +2.75%
Drug Delivery
COLUMBIA LABS INC [CBRX] +11.99%
BIOPROGRESS PLC [BPRG] +4.62%
NOVADEL PHARMA INC [NVD] +1.61%
SKYEPHARMA PLC [SKYE] +1.04%
BENTLEY PHARMACEUTIC [BNT] +0.76%
Drug Manufacturers
CELL THERAPEUTICS [CTIC] +12.96%
AVI BIOPHARMA INC [AVII] +7.93%
RIGEL PHARMACEUTLS [RIGL] +6.21%
AMARIN CORP PLC AD [AMRN] +4.67%
PHARMION CORP [PHRM] +4.27%
Drug Related Products
USANA HEALTH SCIEN [USNA] +4.05%
NATROL INC [NTOL] +3.00%
XELR8 HOLDINGS, INC [BZI] +2.88%
DRAXIS HEALTH INC [DRAX] +0.81%
ZILA INC [ZILA] +0.49%
Generic Drugs
CARACO PHARMA LABS [CPD] +2.08%
ISOLAGEN INC [ILE] +1.58%
BARR PHARMA INC [BRL] +0.30%
PHARMACUTICAL CO [PRX] +0.04%
Medical Appliances & Equipment
VNUS MEDICAL TECHNOL [VNUS] +11.07%
ALPHA INNOTECH [APNO.OB] +10.29%
VOLCANO CORPORATION [VOLC] +5.94%
CELSION CORP [CLN] +5.07%
ROCKWELL MED TECHS [RMTI] +4.26%
Medical Instruments & Supplies
IMPLANT SCIENCES CP [IMX] +4.00%
OPHTHALMIC IMAGING SYS INC [OISI.OB] +3.92%
CARDICA, INC. [CRDC] +3.23%
INOVIO BIOMED CORP [INO] +3.20%
ATRION CP [ATRI] +2.58%
Medical Laboratories & Research
NATL DENTEX CP [NADX] +2.12%
BIO-IMAGING TECH [BITI] +2.02%
PSYCHEMEDICS NEW [PMD] +1.53%
GENOMIC HEALTH, INC. [GHDX] +0.97%
ALLIANCE IMAGING INC [AIQ] +0.65%
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.